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Abstract
The use of imaging represents a major impact on the refinement and the reduction of in vivo studies in
animal models, in particular for allowing longitudinal monitoring of the onset and the progression of
disease within the same animal, and studying the biological effects of drug candidate and their therapeutic
effectiveness. But the use of imaging procedures can affect animal physiology, and the need to anesthetize
the animals for imaging entails potential health risks. During anesthesia, there is an inevitable autonomic
nervous system depression which induces cardiovascular depression, respiratory depression, and
hypothermia. Also other procedures associated with imaging such as animal preparation (e.g., fasting,
premedication), blood sampling, and dosage/contrast agent injections can also affect physiology and
animal welfare. All these factors are likely to have confounding effect on the outcome of the imaging
studies and pose important concerns regarding the animal’s well-being, particularly when imaging immune
deprived animals or diseased animals. We will discuss these challenges and considerations during imaging
to maximize efficacious data while promoting animal welfare.
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1.  Introduction
The use of imaging technologies is instrumental in biomedical research due to their great scope for
noninvasively studying biochemical and biological processes in the living animal. Their application
represents a major impact on the “3Rs” principles particularly in the reduction of animals used for in vivo
studies, allowing longitudinal monitoring of the onset and the progression of disease within the same animal
through serial imaging and also to test the therapeutic effectiveness of new treatment. Preclinical magnetic
resonance imaging (MRI) remains the most versatile imaging modality which has been extensively used for
anatomical, functional, and physiological characterizations of tissues/organs [1]. Current MRI systems can
routinely achieve a spatial resolution of 100 μm in all dimensions in living animals providing high-quality
anatomical detail. But MR techniques can also provide information on chemical composition (spectroscopy)
and other parameters such as cardiovascular function [2] and neuronal network alterations [3]. Its
nonionizing 3D imaging functionality is truly noninvasive avoiding any exposure of the animals to any
ionizing radiation. This is especially important during serial imaging giving an advantage over modalities
such as CT, SPECT, and PET. A challenge is the higher spatial resolution required with rodents compared to
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humans. In order to segment each body into the same number of voxels, the rodent voxel volume must be
approximately 3000 times smaller than that of a human. In MRI, the answer to this challenge lies in higher
magnetic fields system (e.g., 11.7 T), strong magnetic field gradient systems (e.g., 1000 mT/m) [4] and
preclinical-specific radio-frequency coils and cryogenic probes [5]. Overall, MRI methodology provides a
major preclinical refinement and reduction tool, delivering clinically relevant outcomes in a minimally
invasive manner in a living organism, allowing for repetitive monitoring in the same animal, maximizing
biological relevance, thus delivering a rapid, efficacious, and reasonably cost-effective use of animal disease
models. A major difference with human MRI remains which is the need to anesthetize the animals for
imaging, which per se entails potential health risks in the imaged animals. Indeed, during anesthesia there is
inevitable autonomic nervous system depression which induces cardiovascular and respiratory depression
and hypothermia. All these factors have a profound effect on the animal’s homeostasis and may thereby
confound the image quality and interpretation, or statistically speaking lead to bias and increased variability.
In addition, other experimental procedures occasionally performed along with imaging such as fasting,
premedication, blood sampling and the administration of contrast agents or imaging biomarkers can also
affect physiology and animal welfare. Furthermore functional pharmacological blood oxygen level
dependent (BOLD) MRI can be markedly affected by anesthesia due to its effects on blood flow, blood
oxygenation levels, and cardiac and respiratory functions [6]. Similarly, the need for lengthy acquisition
times for ultra-high resolution MRI also poses challenges for adequate physiological monitoring. All these
factors are likely to have confounding effects on the outcome of the imaging studies and pose important
concerns regarding the animal’s well-being, particularly when imaging disease-modeling animals [7].
In the remainder of this chapter we will discuss the challenges associated with setting up and carrying out
preclinical MRI procedures, addressing the protocols related to animal handling, induction and maintenance
of anesthesia and physiological monitoring, to promote appropriate animal care and to minimize potential
confounding effects on imaging outcomes.
2.  Methods
2.1.  Planning and Setting Up an MRI Study
When thinking on undertaking a preclinical MRI study, it is important to allocate enough time for planning,
addressing all the animal regulatory guidelines and defining all scientific objectives. The following protocol
may be used as guidelines.
1. Define specific targets and procedures
• What are the scientific objectives and how are they relevant to the clinical scenario and/or in
vivo mechanistic modeling? Include a clear hypothesis to be tested via the primary (and
optionally secondary) objectives.
• What is the rationale for using imaging, and in particular MRI?
• Which stage of disease models will be used and why? Define why the animal species and
model is being selected.
• Describe the rationale for the specific imaging timeframes used (onset and/or progression of
disease and/or response to treatments).
• Define imaging outcomes (both qualitative and quantitative) and data analysis algorithms.
• Describe how data quality control is handled (e.g., imaging system calibration).
• Draw up prospective plans for further imaging sessions and/or co-registration with other
imaging modalities.
2. Ensure that all animal procedures are approved by the specific institutional animal welfare body
(AWERB-UK [8]; IACUC-USA [9]) and are conform to regulatory frameworks (EU Directive
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2010/63/EU [10]; US-PHS “The Guide for the Care and Use of Laboratory Animals; Health
Research Extension Act of 1985 [11]) for the care and use of animals.
3. For budget preparation, include costs for animal purchase, transport, housing, time for technical and
veterinarian support, imaging acquisition, data storage, processing and analysis.
4. Define experimental procedures, ensuring (1) the animal model can be set up and specific MRI
experiments can be done in the facility, (2) biosafety requirements are fulfilled (e.g., need for
quarantine), (3) general and specific housing capabilities are available, and (4) supporting staff is
trained and available.
5. Design the study including the number of experimental and control groups, steps taken for
randomization and blinding, a workflow to work out the experimental procedures that will be carried
out within the same animal for severity assessment. Check that this is all in accordance with the
ARRIVE guidelines [12].
The experimental protocol should include:
• Health surveillance/general check prior to study.
• Selection of animal strain, sex, age, weight (range), and genotype (e.g., knock-out or transgenic).
• Plan specifics for animal housing (individual/in groups); IVC caging; isolators; specific SPF housing;
specific bedding; cage enrichment.
• Define experimental group, including appropriate any sample size calculation used and number of
independent replications of each experiment.
• Selection of statistical methods to be used for each analysis, including data normalization and a
measure of precision (e.g., standard error or confidence interval).
• Pretreatment: fasting, specific feeding, premedication, contrast agents including dose and route of
administration.
• Anesthesia regime: selection of drug, dosage and route of administration.
• Physiological monitoring (for depth of anesthesia and imaging monitoring) with clear definition of
adverse effects, care procedures, and humane endpoints.
• Record keeping: reporting all the animal procedures, usage, and discharge records according to
regulatory requirements.
2.2.  Transport of Animals to the Imaging Unit and Acclimatization
Animals often have to be transported from general holding rooms to the imaging facility. One consequence is
that this will require full compliance with the institutional health screening controls to minimize disease
transfer to any other animals in the facility. A second consequence is that for the transported animals
themselves experience stress leading to an increase of the glucocorticoid level, a loss in body weight and
immune response suppression which have been observed for up to 48 h after transport in rodents [13].
Therefore an acclimatization period, typically between 3 and 7 days depending on the procedure and
transport duration, is required after animal transport. Imaging facilities should make housing capacity
available to allow for the acclimatization of transferred animals and reduce stress before imaging takes place.
Housing in the imaging facility is also useful for monitoring animal recovery after anesthesia. A sufficiently
long recovery period should also be included after imaging, depending on the type of anesthetic, the length
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of anesthesia, and any experimental procedures carried out. If an imaging unit is integrated within a
centralized animal unit, transport time and acclimatization may be considerably reduced.
2.3.  Animal Preparation for Imaging
Different procedures will be required depending on the animal model used and the in vivo experimental
protocol required prior to imaging. This may include procedures such as fasting, specific treatments/dosing,
and behavior assessments. Such additional procedures need to be well planned ahead and appropriately
monitored. As regulated procedures, these need to be properly reported as per specific regulatory guidelines
(Note, fasting is a regulated procedure). Regular assessments of the animals include regular body weight
measurements and standard clinical checks on such aspects like fur status, general behavior, and peer
interaction, alertness, good food/water uptake, feces control and absence of diarrhea, and face expression
including healthy eyes. Passing these criteria, animals can be accepted into the study. Then, these
measurements and assessments prior to any imaging serve as physiological baseline values.
On the day of imaging, animals may also require more specific interventions such as vessel cannulation,
implantation of ECG probes, and tracheal intubation. These need to be carried out according to institutional
guidelines for aseptic surgery [14] with good thermoregulation control and a suitable analgesic and
anesthesia regime to ensure minimal physiological impact of these interventions. The pre-anesthetic exam
should contain, but is not limited to, confirmation of animal’s identification, sex, age, body weight, body/fur
condition, hydration/color of mucous membranes status, heart rate and rhythm, respiratory rate, signs of
diarrhea, evidence of normal food and water consumption and normal production of urine and feces in the
cage. The body condition of the animal will impact on anesthesia induction, maintenance, and recovery (e.g.,
obese animals may respond more slowly to anesthetics).
Prior to imaging acquisition animals will be placed on the “imaging bed” which will need to be fitted with
anesthesia supply, thermoregulation equipment for the anesthetized animals and physiological monitoring
sensors. Anesthesia regimes and monitoring systems are discussed below.
2.4.  Induction of Anesthesia
Anesthesia is generally required during imaging to ensure humane restraint of the animals. Most anesthetics
induce a certain degree of autonomic nervous system depression, which triggers cardiovascular depression
(e.g., reduction in cardiac output, blood pressure) and respiratory depression (e.g., hypoxia, hypercapnia) and
induces hypothermia, affecting whole body metabolism. Such effects can be critical in laboratory rodents
which have a small body size, high body surface-to-weight ratio, and high metabolic rate, compromising the
pharmacological efficacy of anesthetic agents and their ability to thermoregulate. It is important to ensure
that anesthetized animals remain in a stable physiological state with consistent cardiovascular, respiratory
function and body temperature during imaging.
The experimental protocol should include:
• Animal transport—ensuring biosafety based on health surveillance program.
• Acclimatization period (3–7 days; shorter if integrated imaging & housing units).
• Animal preparation and pretreatments (e.g., dosing/fasting).
• Regular general health status monitoring (body weight) with good record keeping.
2.5.  Anesthesia Regimes
Injectable and inhaled anesthetics are commonly used in preclinical imaging. Gas anesthetics are most
suitable and recommended for imaging due to their rapid onset and recovery times, and faster elimination.
Inhaled anesthetics with medical air or medical oxygen as gas carrier allow for a better control of depth of
anesthesia and degree of oxygenation than injectables [15]. This is particularly critical when undertaking
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long-term imaging procedures due to the risk of developing hypoxia, respiratory depression, hypercapnia,
and acidosis. Dosing with injectables remains challenging due to the lack of interventional management and
when additional dosing is required which can lead to overdosing and intermittent changes on the depth of
anesthesia. Injectables also often cause a prolonged recovery time, in particular opioids with their strong
residual effect [16]. Some injectables can be administered via infusion which may allow to achieve a more
steady plasma concentration over the course of imaging.
Anesthetic dose rates for injectable agents will depend on species used, administration route, age, sex, strain,
body condition, environment, experimental setup, previous drug treatments, and the level of anesthesia
required. During the initial period of use, it is important to monitor animals closely and make any
adjustments necessary in the protocol for subsequent experiments.
2.5.1.  Injectables Anesthetics
The most commonly used injectable anesthesia agents are listed in Table 1 with their individual advantages
and disadvantages and typical dosing regimes.
Table 1
Commonly used injectable anesthesia agents
Agent Advantages Disadvantages Dosing
Fentanyl/fluanisone
(Hypnorm™)
based combination
• Good analgesic
• Sedative
• Need to “top up” for
long-term anesthesia.
• Sedative effect can be
reverse with
buprenorphine to speeds
up recovery time
• Cardiovascular and
respiratory depression
• Poor muscle relaxation
alone
• Prolonged recovery
time
• Hypersensitivity to
noise
Mouse: 10 mL/kg; rat: 2.7 mL/kg
(i.p.)
Hypnorm™/Hypnovel™
(midazolam)/water mixture (1:1:2
vol) (120–140 min sleep time)
Hypnorm  top up 0.3 mL/kg
(mouse) 0.1 mL/kg (rat) i.p. (30–
40 min sleep time)
Ketamine based
combination
• Analgesic effects
• Light sedation
• Wide safety margin
• Can increase blood
pressure
• High muscle rigidity
unless combined with
other agents.
• Increases intracranial
pressure.
• Recovery often with
ataxia and hyper
responsiveness.
Mouse and rats:
Ketamine + medetomidine:
75 mg/kg + 0.5–1 mg/kg i.p.
Ketamine + xylazine 75–
100 mg/kg/10 mg/k i.p. (60–
120 min sleep time)
Atipamezole: 1 mg/kg i.p. (reverse
agent)
Alfaxalone
(Alfaxan)
• Minimal
respiratory/cardiovascular
depression.
• Rapidly metabolized:
good for repeat dosing
• Suitable for long-term
anesthesia
• Administration route IV
(rodents, cats) or IM
(primates)
15–20 mg/kg (mouse) 10–12 mg/kg
(rat) iv (10–15 min sleep time after
bolus)
0.25–0.75 mg/kg/min iv infusion
(long term)
Propofol
(Rapinovet ,
Diprivan )
• Rapidly metabolized,
• Good for continuous
infusion for long-term
anesthesia.
• Rapid recovery
• High safety: can be used
in animals with hepatic or
renal impairment.
• IV use only
• No analgesic properties
• Severe respiratory
depression: risk of apnea
26 mg/kg (mouse) 10–12 mg/kg
(rat) iv (10–15 min sleep time after
bolus)
2–2.5 mg/kg/min iv infusion (long
term-mouse)
(0.5–1 mg/kg/min iv infusion (long
term-rat)
Barbiturates
products
• Sedative effect
• Hypnotic
• Reasonable muscle
relaxation
• No analgesic properties
• Severe respiratory
depression and
hypotensive
• Easy to over does
• High metabolites
accumulation
• Caustic substances: use
only iv route
Pentobarbitone: 40–50 mg/kg i.p.
(mouse) (120–180 min sleep)
Thiopentone: 30 mg/kg iv 15 min
sleep) (rat)
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Agent Advantages Disadvantages Dosing
Chloral hydrate
• Sedative effect
• Hypnotic
• Minimal CVS and
respiratory depression
• No analgesic properties
• Paralytic noted in rats
• Terminal/non-recovery
work only
300–400 mg/kg i.p. (1–2 h sleep
time) (mouse and rats)
a-Chloralose
• Sedative effect
• Hypnotic.
• Suitable for long-term
anesthesia.
• Minimal CVS and
respiratory depression
• No analgesic properties
• IV use only
• Slow induction and
recovery associated with
involuntary excitement
• Terminal/non-recovery
work only
50–60 mg/kg i.p. (rats) 120 mg/kg
i.p. (mouse) (8–12 h; for non-
recovery only)
50 mg/kg iv bolus followed by 25–
40 mg/kg/hr (rats)
Urethane
• Suitable for long-term
anesthesia.
• Minimal CVS and
respiratory depression
• Carcinogenic: only
allowed to be used with
special justification!
• Terminal/non-recovery
work only
0.8–1.3 g/kg, i.p. (mouse and rats)
duration of action 8–10 h
(nonrecovery only)
Avertin
(tribromoethanol)
• Wide safety margin
• Good muscle relaxation
• Rapid induction and
recovery
• Local
irritation/peritonitis
• Handling and storage
safety issues
• Toxic effects
• Pharmaceutical-grade
TBE (e.g., Avertin) is no
longer available:
IACUC/AWERB
0.015 mL/g body wt of 2.5% i.p.
30 min—supplemental doses of
anesthesia: minimum of one-half of
the initial does up to 1 mL max vol
per animal
2.5.2.  Inhalation Anesthesia
Inhalation anesthesia is the recommended method for imaging laboratory animals as this provides a rapid
induction and recovery and since inhalation anesthesia agents are safe, nonirritant, and nonexplosive.
Medical oxygen is commonly used as the carrier with a flow rate between 0.5 and 1.5 L/min. Non-
rebreathing circuits are usually used to ensure minimum dead space and resistance, and resulting
waste/excess gas is removed by a scavenger system to protect lab staff. The most commonly used anesthetic
circuit type for laboratory rodents is Bain’s coaxial T-piece coupled with an open facemask system mounted
to the imaging bed.
The most commonly used inhalation anesthesia agents are listed in Table 2 with their individual advantages
and disadvantages and typical dosing regimes.
Table 2
Commonly used inhalation anesthesia agents
Agent Advantages Disadvantages Dosing
Halothane
• Potent anesthetic
• High therapeutic index
• Rapid induction and recovery (1–
3 min)
• Adequate muscle relaxation
• Nonirritant, nonflammable nor
explosive
• Easy to vaporize
• Highly metabolized (hepatotoxic)
• Cardiovascular depressant
• Moderate hypotension: reduction in
cardiac output and peripheral
vasodilatation)
• Respiratory depressant
• Halothane sensitizes the heart to
catecholamines (sympathetic
stimulation)
Induction: 3–4%
Maintenance 1–2%
(rats and mice)
®
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Agent Advantages Disadvantages Dosing
Isoflurane
• Similar physical properties to
halothane
• Rapid induction and recovery
• Low toxicity and metabolic activity:
highly safe
• Suitable for high frequency and log-
term anesthesia
• Minimal cardiovascular depression
• Moderate respiratory depression
• Good muscle relaxation
• Decreases arterial blood pressure
(vasodilatation)
• More expensive than halothane
• Strong smell; aversive response for
repetitive use
• More potent respiratory depressant
than halothane
Induction: 3–4%
Maintenance 1–2%
(mice); 1.5–2.5%
(rats)
Sevoflurane
• Faster induction and recovery times
(3 × times faster than isoflurane)
• Less respiratory depression that
isoflurane
• Less struggling and excitement
during induction
• Metabolism similar to isoflurane:
good for repetitive and/or long-term
anesthesia
• Blood glucose homeostasis is better
maintained
• Method of choice for PET FDG
myocardium uptake studies
• Expensive but cost coming down
• Costly specific vaporizers
• Provides an equally reliable
anesthesia in laboratory mice.
Induction: 1–8%
Maintenance: 3–
5% (mice and rats)
It is important to appreciate the variation in response to anesthetics between different animal strains and thus,
to reassure and adjust the anesthesia protocol to the particular needs of a given strain and experimental setup.
2.6.  Monitoring and Impact of Anesthesia During Imaging Procedures
Most anesthetic drugs will impact on respiration, the cardiovascular system, and/or thermoregulation. It is
important to monitor the animals during imaging and provide any physiologic support to ensure animal
welfare and also to minimize any confounding effects on data acquisition. The recommended approach is to
monitor respiratory function and body temperature, as the minimum standard applicable during imaging to
control depth of anesthesia. Cardiac function is also highly recommended. Direct visualization is not possible
and it is greatly suggested to use the existing monitoring equipment for laboratory rodents which is tailored
to their small body size, fast cardiac and respiratory rates, and importantly in the case of MRI, is non-
ferromagnetic to avoid any interference with the magnetic field [17, 18]. Most MRI-compatible systems are
based on fiber-optic or carbon fiber equipment and power source or batteries are adequately filtered/isolated
to avoid magnetic interference [19].
While protocols do not specifically define how frequently one should monitor the animals during anesthesia,
it is obvious that the more invasive the procedure and/or the longer time under anesthesia, the more likely it
is to interfere with normal homeostasis and thus greater the need for more frequent/constant monitoring.
Also it is instrumental to support the acquisition of gated imaging, minimizing the effects due to biological
motion and also targeting specific imaging sequences, in a given respiratory or cardiac phase.
The position of the animals and the imaging bed systems used are also crucial, to ensure that the neck and
head are well positioned to avoid restricting the breathing, and also the body and extremities to avoid
restricting the circulation and to avoid any bruising, strains or avulsion in the body structures.
2.6.1.  Temperature
Most anesthetic agents profoundly depress thermoregulation [20]. Rodents are highly susceptible to
hypothermia due to their large surface area-to-body mass ratio and rapid metabolism. This is particularly
critical when imaging nude or hairless mice. Hypothermia will have confounding effects on glucose
metabolism and heart rate, which can significantly affect, e.g., FDG-PET studies and echocardiography
outcomes. Therefore monitoring body core temperature is crucial. This is mostly done using rectal
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thermometers or thermocouples which are well fitted to the MRI systems and generally do interface with an
external heat source such as circulating hot water blankets or blowing air systems that help to maintain the
animal’s body temperature. Hyperthermia is as dangerous as hypothermia, thus the external heat source
should be “thermostatically controlled” and linked to the core temperature reading. Heat loss must also be
minimized during the animal preparation before imaging (e.g., hair removal, alcohol application) and fluid
replacement, if required, should be warmed to 37 °C.
The eyes should be protected both from drying off and exposure keratitis by regular application of
ophthalmic ointment.
2.6.2.  Respiratory System
Most anesthetics are known to cause respiratory depression. Therefore it is important to reduce variability
due to poor ventilation including hypoxia, hypercapnia, and acidosis [21, 22]. Respiratory monitoring is
generally carried out via detecting the breathing motion registered as compressions of a respiratory sensor
placed in contact with the animal’s chest. These systems are extensively used during imaging and highly
compatible with MRI. Motion artifacts due to breathing can be eliminated from the images by employing
gated imaging. Typically the most prominent motion of the diaphragm and abdomen occurs during
inspiration, and acquisitions are generally carried out during expiration.
Other more advanced approaches include the use of arterial blood gas analysis, which is very valuable during
functional MRI. The partial measurements of oxygen (pO ) and carbon dioxide (pCO ) and the pH of the
blood are detected from a single blood sample allowing levels of oxygenation, imbalance of CO  production
and acid-base balance to be monitored. Impaired gas exchange, or hyper- or hypoventilation can be corrected
by changing the anesthetic regime, and when critical through using artificial ventilation. Indeed, some
studies will require the animal to be mechanically ventilated and it is important to ensure that the animal
does not develop hypercapnia or hypoxia. Other advanced respiratory monitoring systems include digitized
systems such as capnographs that measure the CO  level through a highly sensitive infrared spectroscopy
CO  sensor in the inhaled and exhaled gas, based on the CO  values in the venous return to the heart and the
efficacy of breathing. This equipment provides a very good indicator of the respiratory function by
continuous measurements of the CO  level. Capnographs that measure the CO  level in the inhaled and
exhaled gas between inspiration and expiration at the endotracheal tube connector or face masks level are
very good indicator of the respiratory function [23].
2.6.3.  Cardiovascular System
Basic cardiovascular monitoring, including heart rate and blood pressure, is highly recommended.
Electrocardiograms (ECG) are generally used to monitor heart rate and rhythm and help to detect
arrhythmias, myocardial ischemia, or metabolic disorders. ECG measurements are also used to synchronize
the heart rate to the image acquisition, during gated imaging. Non-ferromagnetic electrodes, MRI–
compatible needles or patch electrodes are mostly used. Pulse oximeters are also very useful to monitor
arterial oxygenation and pulse during anesthesia, detecting any changes long before the animal becomes
cyanosed. The system provides real-time continuous measurements of arterial O  saturation, pulse strength,
breathing rate, blood flow and effort to breathe. The systems available for rodents are not invasive and are
MRI compatible [24].
Blood pressure measurements are also used during imaging [25]. The mean arterial pressure (MAP) is the
overall judge of the state of the circulation, being the best indicator on how well tissues are perfused. As the
MAP falls, vital organ auto regulation and perfusion is quickly compromised. Measuring MAP stability is
very important during functional MRI or when assessing the perfusion of contrast agents through specific
tissues/organs during contrast enhanced MRI. The direct blood pressure measurement involves placing a
catheter in an artery and connecting it to a transducer. The procedure is generally invasive as the artery,
femoral or carotid usually, has to be exposed surgically. Indirect methods typically use an inflatable tail cuff
pressure sensor to detect the arterial blood flow [26] but are less accurate than direct ones and generally data
acquisition is intermittent.
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2.6.4.  Repeated and Long-Term Anesthesia
Some imaging protocols may require long acquisition times and/or high frequency imaging with
considerable impact on cumulative time of anesthesia. In these circumstances it is recommended to use
minimally metabolized volatile anesthetics like isoflurane or sevoflurane, which allow for a quick induction,
good surgical anesthesia and fast recovery, so that animals can regain full physiological functions quickly.
Repeat imaging is likely to induce some hypothalamic-pituitary-adrenal (HPA) axis and autonomic nervous
system responses to the chronic stress with prolonged elevation of corticosterone and impairments to
homeostasis [27]. It is of utmost importance to monitor body temperature. Hypo- or hyperthermia will
interfere with many electrophysiological outcome measurements. The extremities and tail should be covered
whenever possible. Long imaging procedures with lengthy anesthesia may seriously compromise the
hydration statues of the animals. Therefore it is important to compensate for the fluid lost and prevent animal
dehydration. Parental administration of warmed fluids (0.9% saline or lactated Ringer’s) may be applied and
ideally also the inspired gases may be humidified to avoid desiccation via the airways. Eye protection may
also be used to help maintain good lubrication of the cornea and also to protect the eyes from exposure
keratitis.
2.6.5.  Ventilation
Some studies will require the animal to be mechanically ventilated, which may have important effects on
thoracic hemodynamics and may also override the autonomic reflex control of breathing, which normally
maintains blood gas homeostasis. When monitoring a ventilated animal, ideally, one should have
oxygen/carbon dioxide monitoring equipment (e.g., pulse oximeter, end tidal capnograph). The ventilation
settings can then be adjusted to try to maintain physiological levels of O /CO . Blood gas and electrolyte
analysis are useful but confer intermittent monitoring, and a local analyzer is needed.
The most commonly observed physiological effects and health risks during anesthesia and troubleshooting
management are listed in Table 3.
Table 3
Commonly physiological effects and management during anesthesia
 Heath risks Troubleshooting issues
Respiration
Hypoxia, hypercapnia and acidosis
Effect exacerbated during prolonged
Impact on HbO /02
High breathing rate:
• Increase anesthesia dose
• Check anesthetic system
Low breathing rate/apnea:
• Animal may be too deep: Lightening or reversing
anesthesia
• Hypothermia: Check temperature
• Hyperventilation in oxygen
• Short term reaction to injectables (e.g., thiopentone)
Respiration fails:
• Manual ventilation if animal is intubated
• Gently massage the chest side to side-not very effective
(if animals is accessible outside the MRI magnet)
• Supply O  even if using injectable anesthesia
• Use specific reverse agents
Cardiac
function
Rodents high heart rate (×10 faster
than humans) and short circulation
time
Profound effect of anesthetics
Heart rate, rhythm and pulse intensity
Tachycardia:
• May be a pain response: Too “light” anesthesia, increase
anesthesia
• Correct any fluid deficit (check for any bleeding)
2 2
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 Heath risks Troubleshooting issues
Bradycardia:
• Animal may be too deep: Lightening or reverse
anesthesia
• Animal too cold: Control body temperature
• Can be surgically induced by vagal reflexes or by
anesthetic drugs
• Atropine may be indicated
Cardiac arrest
• Gently massage the chest side to side-not very effective
• Stop anesthesia and transfer to O  supply only
• Some drugs are effective in larger animals (adrenalin) but
seldom practical for emergency procedures in rodents
Risk of
anesthesia
overdose
Heart rate (high or slow at critical
stage)
Arrythmias
Respiration (high and/or shallow)-
diaphragmatic
Pulse weak
Membranes pale
• Turn off gas anesthetics/administer reversal anesthetic
agent.
• Maintain animal with O  only (or ventilate with oxygen)
• Administer isotonic fluids.
• Warm up the animal slowly to increase body
temperature/metabolism
2.7.  Materials
Table 4 lists physiological parameters and exemplary MRI-compatible systems for monitoring. Respiration
and heart rate signals can be fed into the MR console for gated imaging, e.g., imaging only during exhale
phases. Temperature readings can be used as input to a feedback loop for temperature control.
Table 4
Exemplary systems for MRI-compatible physiological monitoring
Physiological parameter Examples
Respiration monitoring and gating, ECG
monitoring and gating
BioVet (m2m Imaging Corp., USA)
Low-cost solution Uni Jena [28]
Model 1030 monitoring and gating system (Small Animal
Instruments, Inc., USA)
Physioguard II (Minerve, France)
Temperature monitoring
BioVet (m2m imaging corp, USA)
Imaging cells (Minerve, France)
Model 1030 monitoring and gating system (Small Animal
Instruments, Inc., USA)
OTG-M (Opsens, Canada)
Heating systems
Hot air fan with feedback loop (Small Animal Instruments, Inc.,
USA)
Hot air tubes built into animal bed (Minerve, France)
Hot water tubes built into animal bed (aspect imaging, Bruker)
Resistive heating system Oxford Inst. Radiation oncology [28]
Pulse oximetry, heart rate monitoring MouseOx (STARR Life Sciences Corp., USA)MouseSTAT (Kent Scientific Corp., USA)
Respiratory CO  monitoring Capnograph V9004 (Harvard Apparatus, Ltd., UK)Capnoscan (Kent Scientific Corp., USA)
Blood pressure monitoring
Samba Preclin 420/360 transducer (Harvard Apparatus, Ltd.,
UK)
TSD104A blood pressure transducer (Biopac Systems, Inc.,
USA)
2
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2.8.  Recovery
Monitoring should be carried out until the animal has fully recovered from anesthesia, i.e., until the animal
regained full consciousness with essential physiological functions back to normal. Checks should include in
particular respiratory and cardiovascular function and the ability to control body temperature. Only then the
animal may be transferred back to its housing cage.
During recovery, it is important to maintain the core temperature of the animal. Good practice is to place the
animals on their right side or in sternal recumbent position in a warm recovery cage with no sawdust or
suchlike bedding that may be inhaled. If the animals have been under anesthesia for a relatively long time, it
may be worth giving oxygen, fluids and nutrition supplement. This can include oral or parenteral support,
e.g., high-energy moist foods such as nutrient agar, jelly or crushed rodent pellets mixed with water,
presented in a Petri dish or other manner that does not require the animal to reach up high. Additional
analgesia should be provided if the animal has undergone a painful procedure or if there appears to be any
sign of pain [28].
3.  Conclusions and Outlook
Imaging technologies have dramatically increased the efficiency of preclinical studies, providing a powerful,
noninvasive, and clinically translatable means of monitoring disease progression and therapeutic response.
The noninvasive acquisition of detailed in vivo anatomical and functional data represents an important
milestone in refinement and reduction in the use of animal models. However, it is important to continue
refining all the rodent bio-imaging protocols including appropriate anesthetic regimen and monitoring
systems to ensure the animal’s well-being and to minimize stress-related responses that would compromise
the imaging outcomes.
It is important to consolidate good protocols for handling, anesthesia and monitoring the animals suitable to
all the specific needs of a wide range of imaging experiments. This is a rapidly advancing field that holds
great opportunities for further research and technology development. Technological challenges are
addressing faster acquisitions, faster analysis software, and more versatile integrated multimodality imaging.
Imaging companies continue developing and integrating physiological monitoring systems in preclinical
equipment, and strategies are needed to continue supporting further investment and developments in the
field. Similarly, further studies on the impact of frequent and repetitive anesthesia/imaging are needed to
ensure the appropriate severity assessments and its impact on lifetime experience for each studied animal and
to improve their welfare.
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